Avid Bioservices to Participate at BIO International Convention 2019
28 Mai 2019 - 2:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that the company will
participate at the upcoming 2019 BIO International
Convention. Company management will participate in a variety
of convention activities including presentations, panels and
executive interviews related to the CDMO industry within the
BioProcess International (BPI) Theater, as well as booth
presentations and hospitality events within the exhibit hall.
BIO 2019 is being held June 3-6, 2019 in Philadelphia, PA.
Details of Avid’s activities at BIO 2019 are as
follows:
- Avid will host corporate booth #3149 showcasing the company’s
comprehensive range of process development, high quality cGMP
clinical and commercial manufacturing services. Company
representatives will provide a virtual tour of Avid’s
state-of-the-art commercial biomanufacturing suite, which
incorporates a variety of cutting-edge, single-use equipment with
the goal of ultimately accommodating a fully disposable
biomanufacturing process. The facility houses a wide range of
innovative features including modular clean rooms, dedicated
support utilities for each key processing area, and the industry’s
most advanced single-use production systems and flexible
solutions. Uni-directional process flows separate personnel
and materials and provide assurance that the design meets the most
stringent regulatory requirements for commercial biologics drug
substance manufacturing.
- Ray Marzouk, Avid’s vice president of quality, will make a
presentation titled, “Quality Considerations for Introducing New
Products Into Your Facility.” The presentation will take
place from 1:05 – 1:25 p.m. Eastern on Wednesday, June 5th at booth
#3211 within the BPI Theater. It will be part of the BPI
Theater’s “Emerging Techniques, Technologies and Strategies”
track.
- Gene Yoshioka, Avid’s senior director of manufacturing, will
participate in a roundtable panel discussion titled, “Capacity
Challenge: How Single-Use is Feeding the Demand for Commercial
Biologics Manufacturing.” The roundtable discussion will take place
from 1:45 – 2:30 p.m. Eastern on Wednesday, June 5th at booth #3211
within the BPI Theater. It will be part of the BPI Theater’s
“Emerging Techniques, Technologies and Strategies”
track.
- Tracy L. Kinjerski, Avid’s vice president of business
operations, will be interviewed live as part of the BPI Theater’s
“BioProcess Insider Daily.” The live interview will take
place from 10:45 - 11:00 a.m. Eastern on Wednesday, June 5th at
booth #3211 within the BPI Theater. It will be part of the BPI
Theater’s “Emerging Techniques, Technologies and Strategies”
track.
- Avid will also host a hospitability event at its corporate
booth (#3149) from 5:30 -7:00 p.m. Eastern on Tuesday, June 4th as
part of the opening day exhibit hall activities.
For more information on the BIO International
Convention, please visit: http://convention.bio.org/.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and cGMP manufacturing of biopharmaceutical products
derived from mammalian cell culture. The company provides a
comprehensive range of process development, high quality cGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 25 years of
experience producing monoclonal antibodies and recombinant proteins
in batch, fed-batch and perfusion modes, Avid's services include
cGMP clinical and commercial product manufacturing, purification,
bulk packaging, stability testing and regulatory strategy,
submission and support. The company also provides a variety of
process development activities, including cell line development and
optimization, cell culture and feed optimization, analytical
methods development and product
characterization. www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
Von Okt 2023 bis Okt 2024